Papaverine | Papaverine tablets 40 mg 20 pcs.

Latin name

Papaverine

Release form

Tablets.

Packing

20 tablets per pack.

Indications

Spasm of the smooth muscles of the abdominal organs (cholecystitis, pylorospasm, spastic colitis, renal colic)

spasm of the brain vessels

peripheral vasospasm spasm (endarteritis)

angina pectoris in the composition.

Contraindications

Hypersensitivity,

glaucoma,

AV block,

impaired liver function,

advanced age (risk of hyperthermia),

childhood (up to 6 months).

Use during pregnancy and lactation

During pregnancy and during lactation (breastfeeding), the safety and effectiveness of papaverine has not been established.

Composition

1 tablet contains 40 mg of papaverine hydrochloride.

Dosage and administration

Subcutaneously, intramuscularly - 1-2 ml of a 2% solution (20-40 mg) 2-4 times a day, intravenously, slowly 20 mg with preliminary dilution in 10-20 ml of a 0.9% sodium chloride solution.

For elderly patients, the initial single dose is not more than 10 mg.

Inside adults, 40-60 mg 3-4 times a day.

For children from 6 months. up to 2 years - 5 mg, 3-4 years - 5-10 mg, 5-6 years -10 mg, 7-9 years - 10-15 mg, 10-14 years - 15-20 mg 3-4 times a day .

Side effects

Allergic reactions

AV block,

ventricular extrasystole,

decreased blood pressure,

drowsiness,

constipation,

increased activity of hepatic transaminases,

eosino.

Drug Interaction

Reduces the effect of dopegite.

Efficiency decreases when smoking.

Overdose

No data.

Storage conditions

In a dry, dark place at a temperature of no higher than 25 РC.

Expiration

2 years.

Deystvuyuschee substances

Papaverine

Dosage form

dosage form

tablets

Pharmstandard-Leksredstva, Russia